Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma

Table 1 Basic information of stent implantation group and combined treatment group

Group	n	Age (yr)	Sex		Bismuth classification (cases)			Implantation method
			M	F	II	III	IV	Unilateral	Bilateral
Control (35 cases)		61.6 ± 7.1	15	20	2	18	15	4	31
Stent	13		5	8	2	7	4	4	9
Drainage tube	22		10	12	0	11	11	0	22
Combined (37 cases)		58.2 ± 7.7	19	18	4	18	15	7	30
Stent	21		14	7	4	12	5	7	14
Drainage tube	16		5	11	0	6	10	0	16
P-value		0.91	0.49		0.74			0.88

Table 2 Cox regression analysis of risk factors affecting patient prognosis

Influencing factor		Proportional risk factor	95%CI	P-value
Gender	M	1
	F	1.312	0.771-2.223	0.316
Age	≤60 yr	1
	>60 yr	1.819	1.032-3.207	0.038
Bismuth-Corlett classification	II	1
	III	2.633	0.992-6.984	0.052
	IV	6.102	2.040-18.251	0.001
Ways to reduce jaundice	Stenting	1
	Drainage	0.263	0.134-0.516	0.000
Comprehensive treatment	No	1
	Yes	0.039	0.016-0.091	0.000
CA19-9	-	1.002	0.999-1.004	0.147